Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Articles from Emerging Infectious Diseases

Synopses

Stenotrophomonas maltophilia Bloodstream Infection Outbreak in Acute Care Hospital, California, USA, 2022–2023 [PDF - 1.66 MB - 9 pages]
S. M. Khan et al.

Stenotrophomonas maltophilia is an opportunistic bacterial pathogen found in healthcare settings. During May 2022–September 2023, an acute care hospital in northern California, USA, identified 13 S. maltophilia bloodstream infections among intensive care unit patients. Whole-genome sequencing showed the isolates were highly related. We identified risk factors for infection by conducting a matched case–control study, targeted assessment of infection prevention and control practices, and laboratory testing of suspected environmental reservoirs. Among 13 case-patients and 39 control-patients, patients exposed to iodinated contrast (odds ratio [OR] 12.0; 95% CI 2.1–∞), injectable propofol (OR 12.2; 95% CI 1.5–101.4), or fentanyl (OR 9.2; 95% CI 1.8–∞) had increased odds of S. maltophilia bloodstream infection. Although we did not have culture confirmation of a source, we suspect S. maltophilia was transmitted by exposure to nonsterile water from a common source. We recommended infection prevention and control practices to reduce risk for contamination from nonsterile water.

EID Khan SM, Vazquez Deida AA, Langerman S, Hunter JC, Elliott R, Halpin A, et al. Stenotrophomonas maltophilia Bloodstream Infection Outbreak in Acute Care Hospital, California, USA, 2022–2023. Emerg Infect Dis. 2026;32(3):315-323. https://doi.org/10.3201/eid3203.250835
AMA Khan SM, Vazquez Deida AA, Langerman S, et al. Stenotrophomonas maltophilia Bloodstream Infection Outbreak in Acute Care Hospital, California, USA, 2022–2023. Emerging Infectious Diseases. 2026;32(3):315-323. doi:10.3201/eid3203.250835.
APA Khan, S. M., Vazquez Deida, A. A., Langerman, S., Hunter, J. C., Elliott, R., Halpin, A....Trivedi, K. K. (2026). Stenotrophomonas maltophilia Bloodstream Infection Outbreak in Acute Care Hospital, California, USA, 2022–2023. Emerging Infectious Diseases, 32(3), 315-323. https://doi.org/10.3201/eid3203.250835.
Research

Lymphocytic Choriomeningitis Virus Seroprevalence among Urban Pregnant Women and Newborns, Philadelphia, Pennsylvania, USA, 2021 [PDF - 2.15 MB - 8 pages]
D. D. Flannery et al.

Lymphocytic choriomeningitis virus (LCMV) is a globally distributed rodentborne pathogen that can cause severe congenital infections. We conducted a retrospective cross-sectional seroepidemiologic study using remnant serum samples from pregnant women and newborns at 2 hospitals in Philadelphia, Pennsylvania, USA. We tested samples for LCMV IgG and IgM in 3 phases: a high-risk group determined by neighborhood deprivation index scores, a random sample of all birthing women, and a group with prenatally diagnosed neurologic malformations. We found LCMV IgG seroprevalence was 2.4% among 700 high-risk and 2.7% among 300 randomly selected pregnant women. Seroprevalence varied by hospital site, maternal race or ethnicity, and neighborhood deprivation level. All seropositive maternal samples were IgM-negative. Thirty-seven pregnant women carrying fetuses with neurologic malformations were seronegative. Our findings highlight the risk for LCMV exposure in urban settings and emphasize the need for pregnant women to avoid contact with rodents to prevent this rare but serious congenital infection.

EID Flannery DD, Cossaboom CM, Flietstra TD, Barboza A, Burris HH, Puopolo KM, et al. Lymphocytic Choriomeningitis Virus Seroprevalence among Urban Pregnant Women and Newborns, Philadelphia, Pennsylvania, USA, 2021. Emerg Infect Dis. 2026;32(3):324-331. https://doi.org/10.3201/eid3203.250910
AMA Flannery DD, Cossaboom CM, Flietstra TD, et al. Lymphocytic Choriomeningitis Virus Seroprevalence among Urban Pregnant Women and Newborns, Philadelphia, Pennsylvania, USA, 2021. Emerging Infectious Diseases. 2026;32(3):324-331. doi:10.3201/eid3203.250910.
APA Flannery, D. D., Cossaboom, C. M., Flietstra, T. D., Barboza, A., Burris, H. H., Puopolo, K. M....Gordon, S. M. (2026). Lymphocytic Choriomeningitis Virus Seroprevalence among Urban Pregnant Women and Newborns, Philadelphia, Pennsylvania, USA, 2021. Emerging Infectious Diseases, 32(3), 324-331. https://doi.org/10.3201/eid3203.250910.

Projected Effects of Changing Global Tuberculosis Epidemiology on Mycobacterium tuberculosis Immunoreactivity Prevalence, 2024–2050 [PDF - 1.60 MB - 9 pages]
M. Machado et al.

We assessed how evolving global tuberculosis (TB) trends might influence Mycobacterium tuberculosis immunoreactivity and TB risk among persons immigrating to low-incidence countries. We projected annual risk for infection (ARI) in 168 countries for 2024–2050, focusing on China, India, the Philippines, and Vietnam. We applied projections to the age profile of immigrants to 4 low-incidence countries to estimate changes in M. tuberculosis immunoreactivity prevalence and TB risk under status quo and accelerated ARI decline scenarios. In the status quo 2024 estimate, M. tuberculosis immunoreactivity prevalence ranged from 14.7% in China to 40.1% in the Philippines, declining to 5.8% in China and 23.0% in the Philippines by 2050; TB risk also declined. Accelerated ARI reductions yielded greater relative decreases in disease risk than immunoreactivity prevalence. Declining global TB incidence could reduce M. tuberculosis immunoreactivity and disease risk among immigrant populations, which could inform cost–benefit analyses for future TB screening strategies in low-incidence settings.

EID Machado M, Jordan AE, Schwalb A, Houben R, Dodd PJ, Dale K, et al. Projected Effects of Changing Global Tuberculosis Epidemiology on Mycobacterium tuberculosis Immunoreactivity Prevalence, 2024–2050. Emerg Infect Dis. 2026;32(3):332-340. https://doi.org/10.3201/eid3203.251340
AMA Machado M, Jordan AE, Schwalb A, et al. Projected Effects of Changing Global Tuberculosis Epidemiology on Mycobacterium tuberculosis Immunoreactivity Prevalence, 2024–2050. Emerging Infectious Diseases. 2026;32(3):332-340. doi:10.3201/eid3203.251340.
APA Machado, M., Jordan, A. E., Schwalb, A., Houben, R., Dodd, P. J., Dale, K....Campbell, J. R. (2026). Projected Effects of Changing Global Tuberculosis Epidemiology on Mycobacterium tuberculosis Immunoreactivity Prevalence, 2024–2050. Emerging Infectious Diseases, 32(3), 332-340. https://doi.org/10.3201/eid3203.251340.

Genetically Similar High-Risk Strains of Carbapenemase-Producing Enterobacterales in Humans and Companion Animals, United States [PDF - 932 KB - 8 pages]
L. Xiaoli et al.

To elucidate the zoonotic potential of carbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE) in US companion animals (i.e., dogs and cats), we queried the National Center for Biotechnology Pathogen Detection database to identify One Health clusters containing CP-CRE isolates from companion animals and humans. The 11 One Health clusters we found included most (69% [169/246]) publicly available CP-CRE sequences from US companion animals and were from 8 internationally disseminated, high-risk sequence types from 3 bacterial species (Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae). All clustered isolates had New Delhi metallo-β-lactamase–family carbapenemases, and most (92%) carried the blaNDM-5 allele. The One Health clusters included several closely related subclusters with geographically linked isolates from both humans and companion animals. Those results suggest that CP-CRE is an emerging One Health issue and that direct or indirect transmission of CP-CRE is occurring between humans and companion animals in the United States.

EID Xiaoli L, James AE, Stahl AL, Okumura M, Cole SD, Dietrich JM, et al. Genetically Similar High-Risk Strains of Carbapenemase-Producing Enterobacterales in Humans and Companion Animals, United States. Emerg Infect Dis. 2026;32(3):341-348. https://doi.org/10.3201/eid3203.251458
AMA Xiaoli L, James AE, Stahl AL, et al. Genetically Similar High-Risk Strains of Carbapenemase-Producing Enterobacterales in Humans and Companion Animals, United States. Emerging Infectious Diseases. 2026;32(3):341-348. doi:10.3201/eid3203.251458.
APA Xiaoli, L., James, A. E., Stahl, A. L., Okumura, M., Cole, S. D., Dietrich, J. M....Stanton, R. A. (2026). Genetically Similar High-Risk Strains of Carbapenemase-Producing Enterobacterales in Humans and Companion Animals, United States. Emerging Infectious Diseases, 32(3), 341-348. https://doi.org/10.3201/eid3203.251458.

Strongyloides Genetic Diversity among Humans, Dogs, and Nonhuman Primates, Central African Republic, 2016–2022 [PDF - 4.70 MB - 11 pages]
E. Nosková et al.

Strongyloides stercoralis nematode infection occurs in ≈600 million persons worldwide and is listed by the World Health Organization as a neglected tropical disease. Understanding zoonotic potential is critical, especially in areas where humans, domestic animals, and wildlife interact. We explored cross-species sharing of Strongyloides roundworms by analyzing fecal samples from humans, dogs, and nonhuman primates in the Dzanga-Sangha Protected Areas, Central African Republic. We detected positive samples by quantitative PCR and assessed genetic diversity through amplification of the 18S rRNA HVR-IV region and cox1, followed by high-throughput sequencing. Strongyloides prevalence was high in humans, dogs, and gorillas. S. stercoralis haplotype A roundworm dominated in humans but appeared in dogs and apes, whereas S. fuelleborni roundworm was present in all hosts. Shared species and haplotypes indicated zoonotic transmission. Our findings highlight the need for molecular surveillance and emphasize the role of dogs and nonhuman primates as reservoirs, complicating efforts to control infections in human populations.

EID Nosková E, Ilík V, Niatou F, Dumas L, Fuh T, Dicky J, et al. Strongyloides Genetic Diversity among Humans, Dogs, and Nonhuman Primates, Central African Republic, 2016–2022. Emerg Infect Dis. 2026;32(3):349-359. https://doi.org/10.3201/eid3203.250526
AMA Nosková E, Ilík V, Niatou F, et al. Strongyloides Genetic Diversity among Humans, Dogs, and Nonhuman Primates, Central African Republic, 2016–2022. Emerging Infectious Diseases. 2026;32(3):349-359. doi:10.3201/eid3203.250526.
APA Nosková, E., Ilík, V., Niatou, F., Dumas, L., Fuh, T., Dicky, J....Pafčo, B. (2026). Strongyloides Genetic Diversity among Humans, Dogs, and Nonhuman Primates, Central African Republic, 2016–2022. Emerging Infectious Diseases, 32(3), 349-359. https://doi.org/10.3201/eid3203.250526.

Medscape CME Activity
Blastomyces Urine Antigen Testing for Active Case Identification During a Blastomycosis Outbreak [PDF - 652 KB - 8 pages]
A. W. O’Connor et al.

Blastomyces urine antigen testing is a sensitive blastomycosis diagnostic method, but its utility for active case identification during outbreaks is unknown. We evaluated urine antigen testing for identifying blastomycosis cases during a 2023 outbreak at a Michigan, USA, paper mill and assessed demographic and clinical factors associated with test positivity. Approximately 2 months after the outbreak was recognized, we collected work and health information for 603 employees; 95% (n = 578) underwent urine antigen testing and 9% (n = 52) tested positive, including 25 previously undetected cases. Blastomycosis-like symptoms were associated with test positivity (p<0.001), but 10% of employees with positive results were asymptomatic. Recent hospitalization for blastomycosis was associated with test positivity (p = 0.02) and higher antigen levels. Further research into urine antigen testing is needed clarify its suitability for detecting mild and asymptomatic infections during outbreak investigations. Urine antigen testing had high acceptability among employees and effectively identified additional cases.

EID O’Connor AW, Hennessee I, Callaway PC, Stanton ML, Liang X, Park J, et al. Blastomyces Urine Antigen Testing for Active Case Identification During a Blastomycosis Outbreak. Emerg Infect Dis. 2026;32(3):360-367. https://doi.org/10.3201/eid3203.250973
AMA O’Connor AW, Hennessee I, Callaway PC, et al. Blastomyces Urine Antigen Testing for Active Case Identification During a Blastomycosis Outbreak. Emerging Infectious Diseases. 2026;32(3):360-367. doi:10.3201/eid3203.250973.
APA O’Connor, A. W., Hennessee, I., Callaway, P. C., Stanton, M. L., Liang, X., Park, J....Hines, S. E. (2026). Blastomyces Urine Antigen Testing for Active Case Identification During a Blastomycosis Outbreak. Emerging Infectious Diseases, 32(3), 360-367. https://doi.org/10.3201/eid3203.250973.

Seroincidence Rate of Typhoidal Salmonella in Children, Kenya, 2017–2018 [PDF - 1.33 MB - 8 pages]
A. Khan et al.

Enteric fever, caused by Salmonella enterica serovars Typhi and Paratyphi, results in high rates of illness and death globally. The lack of reliable diagnostic assays limits surveillance, leading to major gaps in understanding the population-level burden in low- and middle-income countries. We applied a novel serologic tool measuring IgG responses to hemolysin E to assess typhoidal Salmonella infection rates in children from 4 communities: 2 in western Kenya (Kisumu and Chulaimbo) and 2 in coastal Kenya (Ukunda and Msambweni). We found a substantially higher enteric fever seroincidence rate in coastal Kenya (37/100 person-years) than in western Kenya (3.6/100 person-years). We found a higher seroincidence rate in households with nonpiped water and lower incomes and in neighborhoods with higher population density. Our findings contribute to Kenya's limited enteric fever surveillance data, especially in the coastal regions. Such information underscores the need for public health interventions, such as typhoid conjugate vaccine introduction, in Kenya.

EID Khan A, Kamenskaya P, Rezende I, Mutuku FM, Ndenga B, Jembe Z, et al. Seroincidence Rate of Typhoidal Salmonella in Children, Kenya, 2017–2018. Emerg Infect Dis. 2026;32(3):368-375. https://doi.org/10.3201/eid3203.250469
AMA Khan A, Kamenskaya P, Rezende I, et al. Seroincidence Rate of Typhoidal Salmonella in Children, Kenya, 2017–2018. Emerging Infectious Diseases. 2026;32(3):368-375. doi:10.3201/eid3203.250469.
APA Khan, A., Kamenskaya, P., Rezende, I., Mutuku, F. M., Ndenga, B., Jembe, Z....Charles, R. (2026). Seroincidence Rate of Typhoidal Salmonella in Children, Kenya, 2017–2018. Emerging Infectious Diseases, 32(3), 368-375. https://doi.org/10.3201/eid3203.250469.

Environmental and Phylogenetic Investigations of Aspergillus flavus Outbreak Linked to Contaminated Building Materials, Denmark, 2025 [PDF - 4.53 MB - 12 pages]
A. Gewecke et al.

An Aspergillus flavus outbreak occurred in a tertiary hospital in Denmark. We compared environmental sampling methods, investigated the outbreak through short tandem-repeat genotyping, STRAfla, and analyzed isolate phylogeny using whole-genome sequencing. Paired sampling revealed that air sampling underestimated A. flavus burden (8 CFU/81 air samples vs. 585 CFU/81 surface samples), and culturing at 37°C was superior to 25°C (risk ratio 1.77; p<0.001). STRAfla (n = 145) confirmed clonality of the outbreak isolates. Active growth was identified in a kitchen inside the affected ward. Genetically related isolates were also found in the Department of Clinical Microbiology and in 4 unrelated wood-based building materials from retailers in Denmark. Phylogenetic analyses of 167 isolates supported introduction of A. flavus from building materials. We hypothesize that water damage enabled germination of dormant spores in precontaminated wood-based products. Our findings highlight a risk factor for outbreaks and should inform future hospital construction and infection prevention strategies.

EID Gewecke A, Sieber R, Hallstrøm S, Stegger M, Kolarik B, Knudsen JD, et al. Environmental and Phylogenetic Investigations of Aspergillus flavus Outbreak Linked to Contaminated Building Materials, Denmark, 2025. Emerg Infect Dis. 2026;32(3):376-387. https://doi.org/10.3201/eid3203.251219
AMA Gewecke A, Sieber R, Hallstrøm S, et al. Environmental and Phylogenetic Investigations of Aspergillus flavus Outbreak Linked to Contaminated Building Materials, Denmark, 2025. Emerging Infectious Diseases. 2026;32(3):376-387. doi:10.3201/eid3203.251219.
APA Gewecke, A., Sieber, R., Hallstrøm, S., Stegger, M., Kolarik, B., Knudsen, J. D....Arendrup, M. (2026). Environmental and Phylogenetic Investigations of Aspergillus flavus Outbreak Linked to Contaminated Building Materials, Denmark, 2025. Emerging Infectious Diseases, 32(3), 376-387. https://doi.org/10.3201/eid3203.251219.

Tuberculosis before and during COVID-19 Pandemic, United States, 2010–2023 [PDF - 929 KB - 9 pages]
P. I. Feng et al.

After a steady decline in tuberculosis (TB) during 2010–2019, the United States reported a sharp drop in 2020 and increases during 2021–2023. We assessed whether TB cases during 2020–2023 differed from what was expected in the absence of the COVID-19 pandemic. Using data from the Centers for Disease Control and Prevention National TB Surveillance System and Electronic Disease Notification system, we constructed Poisson regression models to predict frequencies of TB cases, persons receiving TB diagnosis within 1 year of arrival, and persons for whom postarrival TB follow-up was recommended on the basis of 2010–2019 trends. We observed lower than predicted TB cases (7,170 observed, 8,822 predicted), persons receiving diagnosis within 1 year of arrival (208 observed, 259 predicted), and persons with class B TB (4,827 observed, 7,169 predicted) in 2020. Migration changes and COVID-19–related factors likely contributed to the decrease in TB in 2020 and increases during 2021–2023.

EID Feng PI, Phares CR, Pratt R, Self JL. Tuberculosis before and during COVID-19 Pandemic, United States, 2010–2023. Emerg Infect Dis. 2026;32(3):388-396. https://doi.org/10.3201/eid3203.251459
AMA Feng PI, Phares CR, Pratt R, et al. Tuberculosis before and during COVID-19 Pandemic, United States, 2010–2023. Emerging Infectious Diseases. 2026;32(3):388-396. doi:10.3201/eid3203.251459.
APA Feng, P. I., Phares, C. R., Pratt, R., & Self, J. L. (2026). Tuberculosis before and during COVID-19 Pandemic, United States, 2010–2023. Emerging Infectious Diseases, 32(3), 388-396. https://doi.org/10.3201/eid3203.251459.
Policy Review

Rethinking Leptospirosis Prevention, the Philippines [PDF - 1.31 MB - 7 pages]
R. V. Labana

Leptospirosis, the disease caused by infection with Leptospira spp. bacteria, remains a recurring public health challenge in the Philippines, particularly during monsoon floods and typhoon seasons. Despite responsive measures, such as Code White Alerts, standardized treatment protocols, and postflood prophylaxis, cases and associated deaths persist, emphasizing the limitations of reactive strategies. Structural challenges in flood control, urban sanitation, and rodent management hinder long-term prevention. This policy review applies a systems thinking approach to integrate national programs with community-led interventions, recognizing the interlinked roles of environmental management, behavioral change, and grassroots surveillance. Low-cost, context-sensitive actions, such as community drainage clearing, shared protective gear, local rodent-proofing, and barangay-level reporting, can address immediate risks while reinforcing structural initiatives. Embedding those actions within a feedback loop between local actions and national policies fosters resilience, reduces disease incidence, and shifts the paradigm from reactive response to sustainable prevention.

EID Labana RV. Rethinking Leptospirosis Prevention, the Philippines. Emerg Infect Dis. 2026;32(3):397-403. https://doi.org/10.3201/eid3203.251250
AMA Labana RV. Rethinking Leptospirosis Prevention, the Philippines. Emerging Infectious Diseases. 2026;32(3):397-403. doi:10.3201/eid3203.251250.
APA Labana, R. V. (2026). Rethinking Leptospirosis Prevention, the Philippines. Emerging Infectious Diseases, 32(3), 397-403. https://doi.org/10.3201/eid3203.251250.
Dispatches

Optimal Specimens and Lesions for Mpox Diagnosis Using Real-Time PCR, South Korea [PDF - 873 KB - 5 pages]
D. Kim et al.

We analyzed 612 specimens from 135 patients with monkeypox virus clade IIb in South Korea by using real-time PCR. Crusted and anogenital skin lesions and rectal swab specimens demonstrated the highest positivity rates. Viral loads varied by lesion type, anatomic site, and time since symptom onset, supporting our specimen selection for clade IIb detection.

EID Kim D, Muhammad M, Kim J, Kim C, Seo J, Kim D, et al. Optimal Specimens and Lesions for Mpox Diagnosis Using Real-Time PCR, South Korea. Emerg Infect Dis. 2026;32(3):404-408. https://doi.org/10.3201/eid3203.250582
AMA Kim D, Muhammad M, Kim J, et al. Optimal Specimens and Lesions for Mpox Diagnosis Using Real-Time PCR, South Korea. Emerging Infectious Diseases. 2026;32(3):404-408. doi:10.3201/eid3203.250582.
APA Kim, D., Muhammad, M., Kim, J., Kim, C., Seo, J., Kim, D....Chung, Y. (2026). Optimal Specimens and Lesions for Mpox Diagnosis Using Real-Time PCR, South Korea. Emerging Infectious Diseases, 32(3), 404-408. https://doi.org/10.3201/eid3203.250582.

Tuberculosis after TB Preventive Therapy in Persons Living with HIV Recently Initiating Antiretroviral Therapy, Mozambique [PDF - 396 KB - 5 pages]
L. Templin et al.

We investigated tuberculosis (TB) diagnoses among persons living with HIV recently initiated on antiretroviral therapy in Mozambique during 2021–2024 (N = 341,844). TB diagnosis rates were lower among those who completed TB preventive therapy (3.1/1,000 person-years) compared with those who had an incomplete course (11.0/1,000 person-years) or did not start (21.6/1,000 person-years).

EID Templin L, Varajidas Y, Respeito D, Zindoga P, Weiss D, Nguimfack A, et al. Tuberculosis after TB Preventive Therapy in Persons Living with HIV Recently Initiating Antiretroviral Therapy, Mozambique. Emerg Infect Dis. 2026;32(3):409-413. https://doi.org/10.3201/eid3203.251349
AMA Templin L, Varajidas Y, Respeito D, et al. Tuberculosis after TB Preventive Therapy in Persons Living with HIV Recently Initiating Antiretroviral Therapy, Mozambique. Emerging Infectious Diseases. 2026;32(3):409-413. doi:10.3201/eid3203.251349.
APA Templin, L., Varajidas, Y., Respeito, D., Zindoga, P., Weiss, D., Nguimfack, A....José, B. (2026). Tuberculosis after TB Preventive Therapy in Persons Living with HIV Recently Initiating Antiretroviral Therapy, Mozambique. Emerging Infectious Diseases, 32(3), 409-413. https://doi.org/10.3201/eid3203.251349.

Emerging Endemic Area for Blastomycosis, New York, USA, 2000–2024 [PDF - 1.01 MB - 5 pages]
L. E. Ramirez et al.

Blastomycosis is not yet considered endemic in upstate New York, USA; however, cases have increased during the past decade. We performed a retrospective study of 54 laboratory-confirmed cases reported during 2000–2024. Our results demonstrate an increase in incidence over time, indicating that this region represents an emerging endemic area.

EID Ramirez LE, Kostowniak C, Kumar J, Chaturvedi S, Ramani A, Chopra A. Emerging Endemic Area for Blastomycosis, New York, USA, 2000–2024. Emerg Infect Dis. 2026;32(3):414-418. https://doi.org/10.3201/eid3203.251306
AMA Ramirez LE, Kostowniak C, Kumar J, et al. Emerging Endemic Area for Blastomycosis, New York, USA, 2000–2024. Emerging Infectious Diseases. 2026;32(3):414-418. doi:10.3201/eid3203.251306.
APA Ramirez, L. E., Kostowniak, C., Kumar, J., Chaturvedi, S., Ramani, A., & Chopra, A. (2026). Emerging Endemic Area for Blastomycosis, New York, USA, 2000–2024. Emerging Infectious Diseases, 32(3), 414-418. https://doi.org/10.3201/eid3203.251306.

Home-Based Monitoring of Treatment-Related Adverse Events during Drug-Resistant Tuberculosis Treatment, India, 2020–2024 [PDF - 1.47 MB - 5 pages]
M. Ahson et al.

We investigated home-based outreach and point-of-care diagnostic tools for monitoring adverse events among persons treated for drug-resistant tuberculosis in Dharavi, India. Of 974 persons treated, 518 (53%) reported 1,410 adverse events, 126/477 (26%) required regimen change, and 83% of patients completed therapy. Home-based adverse event monitoring can help improve tuberculosis treatment adherence.

EID Ahson M, Shah D, Bhide S, Deshmukh R, Smith JP, Waghmare S, et al. Home-Based Monitoring of Treatment-Related Adverse Events during Drug-Resistant Tuberculosis Treatment, India, 2020–2024. Emerg Infect Dis. 2026;32(3):419-423. https://doi.org/10.3201/eid3203.251893
AMA Ahson M, Shah D, Bhide S, et al. Home-Based Monitoring of Treatment-Related Adverse Events during Drug-Resistant Tuberculosis Treatment, India, 2020–2024. Emerging Infectious Diseases. 2026;32(3):419-423. doi:10.3201/eid3203.251893.
APA Ahson, M., Shah, D., Bhide, S., Deshmukh, R., Smith, J. P., Waghmare, S....Ho, C. S. (2026). Home-Based Monitoring of Treatment-Related Adverse Events during Drug-Resistant Tuberculosis Treatment, India, 2020–2024. Emerging Infectious Diseases, 32(3), 419-423. https://doi.org/10.3201/eid3203.251893.

Rapid Interventions to Limit Outbreak of Invasive Streptococcus pneumoniae in Correctional Facility, North Carolina, USA, 2024 [PDF - 409 KB - 4 pages]
C. D. Gowler et al.

A Streptococcus pneumoniae serotype 4 outbreak in a North Carolina correctional facility resulted in 14 cases (8 suspected, 1 probable, and 5 confirmed). After implementation of movement restrictions and vaccination with 23-valent pneumococcal polysaccharide vaccine, new cases ceased. Serotype 4 presence in this setting raises challenges for an effective vaccination strategy.

EID Gowler CD, Doran E, Williams ND, Albertson JP, Lautenschlager T, Chochua S, et al. Rapid Interventions to Limit Outbreak of Invasive Streptococcus pneumoniae in Correctional Facility, North Carolina, USA, 2024. Emerg Infect Dis. 2026;32(3):424-427. https://doi.org/10.3201/eid3203.250789
AMA Gowler CD, Doran E, Williams ND, et al. Rapid Interventions to Limit Outbreak of Invasive Streptococcus pneumoniae in Correctional Facility, North Carolina, USA, 2024. Emerging Infectious Diseases. 2026;32(3):424-427. doi:10.3201/eid3203.250789.
APA Gowler, C. D., Doran, E., Williams, N. D., Albertson, J. P., Lautenschlager, T., Chochua, S....Wilson, E. (2026). Rapid Interventions to Limit Outbreak of Invasive Streptococcus pneumoniae in Correctional Facility, North Carolina, USA, 2024. Emerging Infectious Diseases, 32(3), 424-427. https://doi.org/10.3201/eid3203.250789.

Extraintestinal Entamoeba moshkovskii Infection, Eastern India [PDF - 2.08 MB - 5 pages]
S. Sardar et al.

Entamoeba moshkovskii is historically considered nonpathogenic. We report a case of severe extraintestinal infection in a patient from eastern India who had abdominal pain, fever, weight loss, anemia, and a splenic abscess. Molecular analysis confirmed E. moshkovskii as the causative agent. This case highlights this parasite’s potential to cause severe illness.

EID Sardar S, Ghosal A, Haldar T, Ganguly B, Das K, Ganguly S. Extraintestinal Entamoeba moshkovskii Infection, Eastern India. Emerg Infect Dis. 2026;32(3):428-432. https://doi.org/10.3201/eid3203.251065
AMA Sardar S, Ghosal A, Haldar T, et al. Extraintestinal Entamoeba moshkovskii Infection, Eastern India. Emerging Infectious Diseases. 2026;32(3):428-432. doi:10.3201/eid3203.251065.
APA Sardar, S., Ghosal, A., Haldar, T., Ganguly, B., Das, K., & Ganguly, S. (2026). Extraintestinal Entamoeba moshkovskii Infection, Eastern India. Emerging Infectious Diseases, 32(3), 428-432. https://doi.org/10.3201/eid3203.251065.

Natural Hendra Virus Infections in Captive Australian Black Flying Foxes, Queensland, Australia [PDF - 1.50 MB - 5 pages]
V. Boyd et al.

We provide evidence for natural Hendra virus infections and associated serology in a cohort of Australian black flying foxes (Pteropus alecto) transferred from Queensland to the Australian Centre for Disease Preparedness in Victoria, Australia. This study supports the likelihood that flying foxes undergo cycles of infection and reinfection and possibly recrudescence.

EID Boyd V, Karawita A, Wang J, Todd S, Riddell S, Layton R, et al. Natural Hendra Virus Infections in Captive Australian Black Flying Foxes, Queensland, Australia. Emerg Infect Dis. 2026;32(3):433-437. https://doi.org/10.3201/eid3203.251350
AMA Boyd V, Karawita A, Wang J, et al. Natural Hendra Virus Infections in Captive Australian Black Flying Foxes, Queensland, Australia. Emerging Infectious Diseases. 2026;32(3):433-437. doi:10.3201/eid3203.251350.
APA Boyd, V., Karawita, A., Wang, J., Todd, S., Riddell, S., Layton, R....Baker, M. L. (2026). Natural Hendra Virus Infections in Captive Australian Black Flying Foxes, Queensland, Australia. Emerging Infectious Diseases, 32(3), 433-437. https://doi.org/10.3201/eid3203.251350.
Research Letters

Detecting Influenza A(H5N1) Viruses through Severe Acute Respiratory Infection Surveillance, Cambodia [PDF - 327 KB - 2 pages]
W. W. Davis et al.

Of 19 human cases of avian influenza A(H5N1) virus infection detected during January 2023–March 2025 in Cambodia, 12 (63%) were detected directly by surveillance for severe acute respiratory infection (SARI) or indirectly by testing ill close contacts. SARI surveillance can supplement other surveillance sources for identifying H5N1 cases.

EID Davis WW, Tan KR, Sar B, Finlay A, Seng H, Long V, et al. Detecting Influenza A(H5N1) Viruses through Severe Acute Respiratory Infection Surveillance, Cambodia. Emerg Infect Dis. 2026;32(3):440-441. https://doi.org/10.3201/eid3203.250832
AMA Davis WW, Tan KR, Sar B, et al. Detecting Influenza A(H5N1) Viruses through Severe Acute Respiratory Infection Surveillance, Cambodia. Emerging Infectious Diseases. 2026;32(3):440-441. doi:10.3201/eid3203.250832.
APA Davis, W. W., Tan, K. R., Sar, B., Finlay, A., Seng, H., Long, V....Uyeki, T. M. (2026). Detecting Influenza A(H5N1) Viruses through Severe Acute Respiratory Infection Surveillance, Cambodia. Emerging Infectious Diseases, 32(3), 440-441. https://doi.org/10.3201/eid3203.250832.

Costs of Extrapulmonary Nontuberculous Mycobacteria Disease, Denmark, 2005–2017 [PDF - 789 KB - 3 pages]
V. Dahl et al.

We estimated the direct and indirect costs associated with extrapulmonary nontuberculous mycobacteria (ENTM) disease in Denmark during 2005–2017. ENTM disease was associated with substantially higher healthcare costs, lower employment income, and increased public benefits before, around, and after diagnosis. Our findings highlight the substantial socioeconomic burden associated with ENTM disease.

EID Dahl V, Pedersen A, Ibsen M, Hilberg O, Løkke A, Fløe A. Costs of Extrapulmonary Nontuberculous Mycobacteria Disease, Denmark, 2005–2017. Emerg Infect Dis. 2026;32(3):442-444. https://doi.org/10.3201/eid3203.251548
AMA Dahl V, Pedersen A, Ibsen M, et al. Costs of Extrapulmonary Nontuberculous Mycobacteria Disease, Denmark, 2005–2017. Emerging Infectious Diseases. 2026;32(3):442-444. doi:10.3201/eid3203.251548.
APA Dahl, V., Pedersen, A., Ibsen, M., Hilberg, O., Løkke, A., & Fløe, A. (2026). Costs of Extrapulmonary Nontuberculous Mycobacteria Disease, Denmark, 2005–2017. Emerging Infectious Diseases, 32(3), 442-444. https://doi.org/10.3201/eid3203.251548.

Oestrus ovis Nasal Myiasis with Pupation in Human Host, Greece, October 2025 [PDF - 509 KB - 3 pages]
I. P. Kioulos et al.

We report a case of human Oestrus ovis nasal myiasis in Greece, in which pupation occurred within the human host. Ten larvae in various stages of development and 1 puparium were expelled or extracted from the patient’s maxillary sinus. Diagnosis was confirmed through morphologic identification and by PCR, followed by DNA sequencing.

EID Kioulos IP, Kokkas E, Piperaki E. Oestrus ovis Nasal Myiasis with Pupation in Human Host, Greece, October 2025. Emerg Infect Dis. 2026;32(3):445-447. https://doi.org/10.3201/eid3203.251077
AMA Kioulos IP, Kokkas E, Piperaki E. Oestrus ovis Nasal Myiasis with Pupation in Human Host, Greece, October 2025. Emerging Infectious Diseases. 2026;32(3):445-447. doi:10.3201/eid3203.251077.
APA Kioulos, I. P., Kokkas, E., & Piperaki, E. (2026). Oestrus ovis Nasal Myiasis with Pupation in Human Host, Greece, October 2025. Emerging Infectious Diseases, 32(3), 445-447. https://doi.org/10.3201/eid3203.251077.

CCHFV Seroprevalence among Hunter-Gatherers, Northeastern Democratic Republic of the Congo [PDF - 314 KB - 3 pages]
D. M. Kasumba et al.

We evaluated human Crimean-Congo hemorrhagic fever virus (CCHFV) seroprevalence in hunter-gatherer populations of northeastern Democratic Republic of the Congo. We tested blood from 300 participants for CCHFV antibodies; 4% were CCHFV-positive. CCHFV likely has been circulating undetected in the country, indicating the need for a more robust surveillance system.

EID Kasumba DM, Shamamba SM, Mubiala AY, Bazola BN, Horton AC, Ndawula C, et al. CCHFV Seroprevalence among Hunter-Gatherers, Northeastern Democratic Republic of the Congo. Emerg Infect Dis. 2026;32(3):447-449. https://doi.org/10.3201/eid3203.251171
AMA Kasumba DM, Shamamba SM, Mubiala AY, et al. CCHFV Seroprevalence among Hunter-Gatherers, Northeastern Democratic Republic of the Congo. Emerging Infectious Diseases. 2026;32(3):447-449. doi:10.3201/eid3203.251171.
APA Kasumba, D. M., Shamamba, S. M., Mubiala, A. Y., Bazola, B. N., Horton, A. C., Ndawula, C....Mulangu, J. (2026). CCHFV Seroprevalence among Hunter-Gatherers, Northeastern Democratic Republic of the Congo. Emerging Infectious Diseases, 32(3), 447-449. https://doi.org/10.3201/eid3203.251171.

Occupational Transmission of Extensively Drug-Resistant Tuberculosis, France [PDF - 397 KB - 3 pages]
C. Poignon et al.

We report occupational transmission of extensively drug-resistant tuberculosis (TB) to a healthcare worker in France receiving tumor necrosis factor α inhibitor therapy. Despite airborne precautions, the healthcare worker contracted TB working in a high-risk unit. This case underscores that immunocompromised healthcare workers should not be assigned to frontline TB care in high-risk settings.

EID Poignon C, Vandenbos F, Risso K, Viard D, Gydé E, Gaudart A, et al. Occupational Transmission of Extensively Drug-Resistant Tuberculosis, France. Emerg Infect Dis. 2026;32(3):449-451. https://doi.org/10.3201/eid3203.251099
AMA Poignon C, Vandenbos F, Risso K, et al. Occupational Transmission of Extensively Drug-Resistant Tuberculosis, France. Emerging Infectious Diseases. 2026;32(3):449-451. doi:10.3201/eid3203.251099.
APA Poignon, C., Vandenbos, F., Risso, K., Viard, D., Gydé, E., Gaudart, A....Carles, M. (2026). Occupational Transmission of Extensively Drug-Resistant Tuberculosis, France. Emerging Infectious Diseases, 32(3), 449-451. https://doi.org/10.3201/eid3203.251099.

Mycobacterium nanjing sp. nov. Isolated from Cutaneous Infection, China [PDF - 727 KB - 3 pages]
Y. Zou et al.

We report a case of a cutaneous infection in an immunocompetent person in China caused by an uncharacterized Mycobacterium strain. The patient isolate was identified as a novel species by whole-genome sequencing. We propose Mycobacterium nanjing sp. nov. as the name for this new species.

EID Zou Y, Mei Y, Zhang W, Shi Y, Jiang H, Huang Y, et al. Mycobacterium nanjing sp. nov. Isolated from Cutaneous Infection, China. Emerg Infect Dis. 2026;32(3):452-454. https://doi.org/10.3201/eid3203.252001
AMA Zou Y, Mei Y, Zhang W, et al. Mycobacterium nanjing sp. nov. Isolated from Cutaneous Infection, China. Emerging Infectious Diseases. 2026;32(3):452-454. doi:10.3201/eid3203.252001.
APA Zou, Y., Mei, Y., Zhang, W., Shi, Y., Jiang, H., Huang, Y....Wang, H. (2026). Mycobacterium nanjing sp. nov. Isolated from Cutaneous Infection, China. Emerging Infectious Diseases, 32(3), 452-454. https://doi.org/10.3201/eid3203.252001.

Cutaneous Paraconiothyrium cyclothyrioides Infection in Lung Transplant Recipient, Georgia, USA [PDF - 1.75 MB - 4 pages]
C. Mackey et al.

We report a cutaneous infection caused by Paraconiothyrium cyclothyrioides, a rare environmental mold, in a lung transplant recipient in Georgia, USA. The infection resolved with posaconazole after substantial diagnostic delays and related side effects. This case underscores the need for improved clinical awareness, diagnostic testing, treatments, and surveillance for such infections.

EID Mackey C, Thomas S, Witt LS, Sajewski E, Lockhart SR, Pouch SM, et al. Cutaneous Paraconiothyrium cyclothyrioides Infection in Lung Transplant Recipient, Georgia, USA. Emerg Infect Dis. 2026;32(3):454-457. https://doi.org/10.3201/eid3203.251042
AMA Mackey C, Thomas S, Witt LS, et al. Cutaneous Paraconiothyrium cyclothyrioides Infection in Lung Transplant Recipient, Georgia, USA. Emerging Infectious Diseases. 2026;32(3):454-457. doi:10.3201/eid3203.251042.
APA Mackey, C., Thomas, S., Witt, L. S., Sajewski, E., Lockhart, S. R., Pouch, S. M....Gold, J. (2026). Cutaneous Paraconiothyrium cyclothyrioides Infection in Lung Transplant Recipient, Georgia, USA. Emerging Infectious Diseases, 32(3), 454-457. https://doi.org/10.3201/eid3203.251042.

Indeterminant Interferon-γ Release Assays in Refugee Children with Splenomegaly, Uganda, 2020–2023 [PDF - 358 KB - 3 pages]
C. R. Phares et al.

We observed a novel association between splenomegaly and indeterminate interferon-γ release assays in refugee children 5–14 years of age in Uganda. Those demonstrating splenomegaly were 4 times more likely to have indeterminate results. Among refugee children 2–4 years of age, >10% had indeterminate results even without splenomegaly.

EID Phares CR, Mwesigwa M, Toney SR. Indeterminant Interferon-γ Release Assays in Refugee Children with Splenomegaly, Uganda, 2020–2023. Emerg Infect Dis. 2026;32(3):457-459. https://doi.org/10.3201/eid3203.251200
AMA Phares CR, Mwesigwa M, Toney SR. Indeterminant Interferon-γ Release Assays in Refugee Children with Splenomegaly, Uganda, 2020–2023. Emerging Infectious Diseases. 2026;32(3):457-459. doi:10.3201/eid3203.251200.
APA Phares, C. R., Mwesigwa, M., & Toney, S. R. (2026). Indeterminant Interferon-γ Release Assays in Refugee Children with Splenomegaly, Uganda, 2020–2023. Emerging Infectious Diseases, 32(3), 457-459. https://doi.org/10.3201/eid3203.251200.

Two Cases of Posttraumatic Kosakonia Infection, Argentina, 2023 [PDF - 703 KB - 4 pages]
C. Barberis et al.

We describe 2 plant-associated posttraumatic Kosakonia infections in Argentina. Facing biochemical and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry limitations, we used whole-genome sequencing to successfully identify K. cowanii and K. oryzae as the causative agents. Our data highlight the crucial role of genomics in correctly identifying these underestimated emerging pathogens.

EID Barberis C, Haim M, Zomero P, Traglia G, Ellis A, Cittadini R, et al. Two Cases of Posttraumatic Kosakonia Infection, Argentina, 2023. Emerg Infect Dis. 2026;32(3):459-462. https://doi.org/10.3201/eid3203.251714
AMA Barberis C, Haim M, Zomero P, et al. Two Cases of Posttraumatic Kosakonia Infection, Argentina, 2023. Emerging Infectious Diseases. 2026;32(3):459-462. doi:10.3201/eid3203.251714.
APA Barberis, C., Haim, M., Zomero, P., Traglia, G., Ellis, A., Cittadini, R....Vay, C. (2026). Two Cases of Posttraumatic Kosakonia Infection, Argentina, 2023. Emerging Infectious Diseases, 32(3), 459-462. https://doi.org/10.3201/eid3203.251714.

Mycobacterium riyadhense Pulmonary Disease after Relocation from Saudi Arabia, Japan [PDF - 2.40 MB - 4 pages]
T. Ozawa et al.

We report a case of Mycobacterium riyadhense pulmonary disease in a patient who relocated from Saudi Arabia to Japan. Epidemiologic data and whole-genome analyses of the isolated strains suggested that the infection might have been acquired in Saudi Arabia and persisted, rather than a recent local acquisition in Japan.

EID Ozawa T, Komine T, Nakayama S, Suzuki Y, Hasegawa N, Fukunaga K, et al. Mycobacterium riyadhense Pulmonary Disease after Relocation from Saudi Arabia, Japan. Emerg Infect Dis. 2026;32(3):462-465. https://doi.org/10.3201/eid3203.251418
AMA Ozawa T, Komine T, Nakayama S, et al. Mycobacterium riyadhense Pulmonary Disease after Relocation from Saudi Arabia, Japan. Emerging Infectious Diseases. 2026;32(3):462-465. doi:10.3201/eid3203.251418.
APA Ozawa, T., Komine, T., Nakayama, S., Suzuki, Y., Hasegawa, N., Fukunaga, K....Asakura, T. (2026). Mycobacterium riyadhense Pulmonary Disease after Relocation from Saudi Arabia, Japan. Emerging Infectious Diseases, 32(3), 462-465. https://doi.org/10.3201/eid3203.251418.

lsaC and Tandem lsaE-lnuB Resistance Genes in Invasive Group A Streptococcus [PDF - 1.11 MB - 5 pages]
B. Beall et al.

Among >16,500 recently recovered invasive Streptococcus pyogenes isolates, we detected 9 independent acquisitions of lsaC or tandem lsaE-lnuB genes, which are known to confer resistance to pleuromutilins and clindamycin. Continued awareness of the evolving S. pyogenes antimicrobial resistosome is important for future infection treatment considerations.

EID Beall B, Mathis S, Li Z, Rivers J, Venero A, Metcalf BJ, et al. lsaC and Tandem lsaE-lnuB Resistance Genes in Invasive Group A Streptococcus. Emerg Infect Dis. 2026;32(3):465-469. https://doi.org/10.3201/eid3203.251776
AMA Beall B, Mathis S, Li Z, et al. lsaC and Tandem lsaE-lnuB Resistance Genes in Invasive Group A Streptococcus. Emerging Infectious Diseases. 2026;32(3):465-469. doi:10.3201/eid3203.251776.
APA Beall, B., Mathis, S., Li, Z., Rivers, J., Venero, A., Metcalf, B. J....Chochua, S. (2026). lsaC and Tandem lsaE-lnuB Resistance Genes in Invasive Group A Streptococcus. Emerging Infectious Diseases, 32(3), 465-469. https://doi.org/10.3201/eid3203.251776.
Emerging Infection Networks Letter

Query into Tuberculosis Infection Screening and Management among Pregnant Migrants, Europe [PDF - 330 KB - 3 pages]
F. Puviani et al.

Pregnant migrant women face increased tuberculosis vulnerability. We queried clinicians in Europe on Mycobacterium tuberculosis infection screening and management among pregnant migrants. Fewer than half reported routinely performing screening, and diagnostic and preventive practices varied widely. Those responses highlight substantial heterogeneity and uncertainty in current M. tuberculosis infection screening practices.

EID Puviani F, Zaffagnini A, Mazzi C, Cirillo D, Di Gennaro F, Farkas F, et al. Query into Tuberculosis Infection Screening and Management among Pregnant Migrants, Europe. Emerg Infect Dis. 2026;32(3):469-471. https://doi.org/10.3201/eid3203.251775
AMA Puviani F, Zaffagnini A, Mazzi C, et al. Query into Tuberculosis Infection Screening and Management among Pregnant Migrants, Europe. Emerging Infectious Diseases. 2026;32(3):469-471. doi:10.3201/eid3203.251775.
APA Puviani, F., Zaffagnini, A., Mazzi, C., Cirillo, D., Di Gennaro, F., Farkas, F....Ursini, T. (2026). Query into Tuberculosis Infection Screening and Management among Pregnant Migrants, Europe. Emerging Infectious Diseases, 32(3), 469-471. https://doi.org/10.3201/eid3203.251775.
Another Dimension

Everything is Tuberculosis: A Portrait of Connection [PDF - 242 KB - 2 pages]
N. M. M’ikanatha
EID M’ikanatha NM. Everything is Tuberculosis: A Portrait of Connection. Emerg Infect Dis. 2026;32(3):438-439. https://doi.org/10.3201/eid3203.260264
AMA M’ikanatha NM. Everything is Tuberculosis: A Portrait of Connection. Emerging Infectious Diseases. 2026;32(3):438-439. doi:10.3201/eid3203.260264.
APA M’ikanatha, N. M. (2026). Everything is Tuberculosis: A Portrait of Connection. Emerging Infectious Diseases, 32(3), 438-439. https://doi.org/10.3201/eid3203.260264.
Online Reports

New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group [PDF - 895 KB - 9 pages]
A. C. Pasqualotto et al.

Histoplasmosis remains a neglected yet deadly fungal infection, disproportionately affecting persons living with HIV/AIDS and other immunocompromised populations in endemic regions. Despite the World Health Organization’s designation of Histoplasma as a high-priority pathogen, the disease remains underdiagnosed and excluded from national surveillance systems, resulting in delayed treatment and high death rates. To coordinate a global response, the International Society for Human and Animal Mycology convened a Histoplasmosis Working Group during its 2025 congress in Brazil. Experts engaged in structured discussions across 5 domains: awareness, research, diagnostics and treatment, capacity building, and fungal biology. The group highlighted persistent diagnostic delays, underuse of antigen testing, and poor access to liposomal amphotericin B and itraconazole. Innovations such as lateral flow assays and molecular tools were discussed, alongside the need for biobanks and validated diagnostic algorithms. A global 90–90–90 target for histoplasmosis by 2030 was proposed to improve diagnosis, treatment, and survival.

EID Pasqualotto AC, Denning DW, Le T, Govender NP, Hagen F, Zancope-Oliveira RM, et al. New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group. Emerg Infect Dis. 2026;32(3):1-9. https://doi.org/10.3201/eid3203.251165
AMA Pasqualotto AC, Denning DW, Le T, et al. New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group. Emerging Infectious Diseases. 2026;32(3):1-9. doi:10.3201/eid3203.251165.
APA Pasqualotto, A. C., Denning, D. W., Le, T., Govender, N. P., Hagen, F., Zancope-Oliveira, R. M....Adenis, A. (2026). New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group. Emerging Infectious Diseases, 32(3), 1-9. https://doi.org/10.3201/eid3203.251165.
Corrections

Correction: Vol. 32, No. 1 [PDF - 161 KB - 1 page]
EID Correction: Vol. 32, No. 1. Emerg Infect Dis. 2026;32(3):471. https://doi.org/10.3201/eid3203.c13203
AMA Correction: Vol. 32, No. 1. Emerging Infectious Diseases. 2026;32(3):471. doi:10.3201/eid3203.c13203.
APA (2026). Correction: Vol. 32, No. 1. Emerging Infectious Diseases, 32(3), 471. https://doi.org/10.3201/eid3203.c13203.
About the Cover

Romanticism at the Edge of Death [PDF - 1.03 MB - 3 pages]
T. Chorba
EID Chorba T. Romanticism at the Edge of Death. Emerg Infect Dis. 2026;32(3):472-474. https://doi.org/10.3201/eid3203.ac3203
AMA Chorba T. Romanticism at the Edge of Death. Emerging Infectious Diseases. 2026;32(3):472-474. doi:10.3201/eid3203.ac3203.
APA Chorba, T. (2026). Romanticism at the Edge of Death. Emerging Infectious Diseases, 32(3), 472-474. https://doi.org/10.3201/eid3203.ac3203.
Page created: March 09, 2026
Page updated: March 25, 2026
Page reviewed: March 25, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external